Gross member additions of approximately 399,000 at an average cost per acquisition of $90 Revenue of $78.9 million, representing a 33% increase over the prior year quarter Cash provided by operations of $2.6 million and $17.5 million, respectively, for the three and six month periods ended June 30, 2014
INDIANAPOLIS, July 23, 2014 (GLOBE NEWSWIRE) -- Angie's List, Inc. (Nasdaq:ANGI) announced today second quarter 2014 financial results for the quarter ended June 30, 2014.
By Rex Crum, MarketWatch
SAN FRANCISCO (MarketWatch) -- Angie's List Inc. shares plummeted 22% Thursday, as at least six Wall Street analysts cut their ratings on the stock after the online professional-services recommendation company delivered what could best be described as disappointing second-quarter results and a weaker-than-expected third quarter forecast.
INDIANAPOLIS, July 9, 2014 (GLOBE NEWSWIRE) -- Angie's List (Nasdaq:ANGI) , announced today that its second quarter 2014 financial results will be released on Wednesday, July 23, 2014, after the close of the market.
ALBANY, N.Y., July 21, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today receipt of an Innovative Technology Contract for the Company's BioFlo PICC and BioFlo Port products from Novation, the leading health care supply chain expertise, analytics and contracting company.
Fourth Quarter of Fiscal 2014 Net sales increased 4% to $94.1 million; Average Daily Sales grew 7%, excluding supply agreement Q4 FY14 GAAP loss of $0.03 per share; Non-GAAP adjusted net income, excluding amortization, of $0.18 per share Q4 FY14 Operating cash flow of $10.1 million Company introduces financial guidance for FY2015
ALBANY, N.Y., July 23, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fourth quarter and fiscal year ended May 31, 2014.
First Quarter of Fiscal 2015 Net sales increased 4% to $87.3 million; Sales grew 5%, excluding supply agreement Q1 FY15 GAAP $0.02; Non-GAAP adjusted net income of $0.16 per share Q1 FY15 EBITDA of $10.8 million, Adjusted EBITDA of $15.3 million Company provides second quarter guidance and increases full-year outlook Company expects to make non-material revisions to Fiscal 2014 and prior period results
ALBANY, N.Y., Oct.
ALBANY, N.Y., July 8, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2014 fourth quarter and full-year ended May 31, 2014, on Wednesday, July 23, 2014, after the close of the U.S. financial markets.
COLORADO SPRINGS, Colo., July 9, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its wholly-owned subsidiary, AngioScore, Inc., developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, launched its new 200 mm length AngioSculpt ® PTA Scoring Balloon Catheters for the treatment of Peripheral Artery Disease (PAD) above-the-knee (ATK).
The new AngioSculpt catheters received U.S. Food and Drug Administration (FDA) 510(k) clearance to be marketed for the dilatation of lesions in the iliac, femoral, iliofemoral, popliteal, infra-popliteal, and renal arteries, and to treat obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
By Judy McKinnon
Global mining giant Anglo American plc said Thursday it will place its Peace River Coal operations in northern British Columbia on care and maintenance due to a continued slump in coking coal prices.
JOHANNESBURG, SOUTH AFRICA --
JOHANNESBURG, SOUTH AFRICA--(Marketwired - August 11, 2014) - AngloGold Ashanti (NYSE: AU) reported a 17% increase in production for the second quarter compared with the same period a year earlier, as its two new mines continued to contribute lower-cost ounces, and a strong safety performance helped its South Africa operations improve their contribution.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.